搜索临床试验以:PRO-148 Ophthalmic Solution
总计2020个结果
-
Beijing Children's HospitalHopital Universitaire Robert-Debre; Shandong University; Rennes University Hospital招聘中
-
University of California, San FranciscoDartmouth-Hitchcock Medical Center; Aravind Eye Hospitals, India; That Man May See, Inc.完全的
-
Sylhet M.A.G.Osmani Medical CollegeUniversity of Edinburgh完全的
-
Tomas Bata Hospital, Czech RepublicFaculty Hospital Kralovske Vinohrady完全的
-
University of North Carolina, Chapel HillUniversity of Colorado, Denver; Baylor College of Medicine; Washington University School of Medicine 和其他合作者终止
-
SanofiRegeneron Pharmaceuticals完全的
-
Healeon Medical IncTerry, Glenn C., M.D.; Ministry of Health, Honduras; Robert W. Alexander, MD邀请报名
-
University of WashingtonNational Cancer Institute (NCI); National Institutes of Health (NIH)终止宫颈腺癌 | 宫颈腺鳞癌 | 宫颈鳞状细胞癌,未另行说明 | 复发性宫颈癌 | 宫颈未分化癌 | IIA期宫颈癌 | IIB期宫颈癌 | III期宫颈癌 | IVA 期宫颈癌 | IB2期宫颈癌 | IIIA期宫颈癌 | IIIB 期宫颈癌 | II期宫颈癌美国, 香港, 加拿大
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; AIDS Clinical Trials Group; SAb Biotherapeutics... 和其他合作者完全的
-
University of Kansas Medical CenterNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.招聘中转移性黑色素瘤 | 不可切除的黑色素瘤 | 病理学阶段 IIIC 皮肤黑色素瘤 AJCC v8 | 临床 IV 期皮肤黑色素瘤 AJCC v8美国
-
Millennium Pharmaceuticals, Inc.完全的
-
Sanofi完全的2型糖尿病美国, 加拿大, 智利, 捷克共和国, 爱沙尼亚, 法国, 德国, 匈牙利, 意大利, 拉脱维亚, 立陶宛, 墨西哥, 波兰, 罗马尼亚, 俄罗斯联邦, 西班牙, 乌克兰, 英国
-
Pierre Fabre Dermo CosmetiqueQuanta Medical未知
-
University of UlmAnticancer Fund, Belgium; Reliable Cancer Therapies完全的
-
Federal University of São PauloFaculdade de Ciências Médicas da Santa Casa de São Paulo未知
-
Alexion PharmaceuticalsCelerion; Achillion, a wholly owned subsidiary of Alexion完全的
-
Agios Pharmaceuticals, Inc.完全的